Target intelligence / Profile preview

Cell-cell and cell-matrix interfaces

Molecular classification
Other, Cell adhesion molecule, Integrin, Cadherin, Selectin, Immunoglobulin superfamily member
01

Overview

Cell-cell and cell-matrix interfaces describe the **specialized contact points and molecular assemblies that mediate adhesion and communication between cells and between cells and the extracellular matrix**. Key molecular families include:\n - **Cell adhesion molecules (CAMs)**, which bind cells to each other or to the ECM and include integrins, cadherins, selectins, and immunoglobulin superfamily members[2][3][6][4]. \n - **Matrix receptors** (notably integrins), which link the cytoskeleton to ECM proteins and mediate bidirectional signaling influencing cell shape, proliferation, movement, and survival[1][5].\nThese interfaces are crucial for maintaining tissue architecture, orchestrating cell signaling, enabling immune surveillance, and regulating morphogenetic processes in development and wound repair. Aberrations in these interactions are central to the pathogenesis of cancer metastasis, immune and inflammatory diseases, and other disorders[2][6][8].\n\n**Note:** For target annotation and database structuring, this entry ("Cell-cell and cell-matrix interfaces") should not be stored as a distinct canonical target. Instead, use the specific molecules (e.g., "Integrin alpha-4", "E-cadherin", "Intercellular adhesion molecule 1") that mediate these interfaces for actionable therapeutic or biomarker information.

Other names
Cell adhesion molecules and matrix receptorsCell-cell junctions and cell-matrix junctionsCAMs and ECM receptors
02

Mechanism of action

Inhibition or activation of specific adhesion molecule function (e.g., blocking integrin-ligand binding)\nModulation of signal transduction downstream of adhesion molecule engagement

03

Biological functions

Cell adhesionSignal transductionTissue morphogenesisCell migrationImmune responseCell proliferationApoptosisBarrier formation
04

Disease associations

Cancer (especially metastasis)InflammationImmune deficienciesWound healing disordersNeurodegenerative diseasesCardiovascular disease
05

Safety considerations

Unintended disruption of tissue integrityImmunosuppressionImpaired wound healingIncreased risk of infection

Beyond the preview

Go deeper on Cell-cell and cell-matrix interfaces.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-cell and cell-matrix interfaces.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call